Stratus CS Acute Care D-Dimer Testpak, Dilpak, Calpak
Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control. 510(k) K063356, from Dade Behring, Inc. (Newark, DE). Product code DAP, class 2.
As of Nov 20, 2026, K063356 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Mar 23, 2007 after 136 days, with 1 recall tied to it in FDA's recall database.
- Review time: 136 days
- Recalls: 1
- Cited as a predicate by: 1 device
The Stratus® CS Acute Care™ D-dimer (DDMR) method is an in vitro diagnostic test for the quantitative measurement of cross-linked fibrin degradation products (D-dimer) in human citrated or heparinized plasma. The Stratus® CS Acute Care™ DDMR method is intended for use as an aid in the diagnosis of venous thromboembolism (VTE) [deep vein thrombosis (DVT) or pulmonary embolism (PE)].
- Stratus CS D-Dimer (Ddmr) Method (Testpak & Dilpak), Models Cddmr & Cddmr-DK022976 · Dade Behring, Inc. · Jan 16, 2003
- Stratus CS D-DimerK051597 · Dade Behring, Inc. · Aug 17, 2005
- Innovance D-Dimer and Innovance D-Dimer ControlsK081732 · Siemens Healthcare Diagnostics · Oct 24, 2008
| Started | Recall | Status |
|---|---|---|
| Jun 7, 2012 | Z-2283-2012Siemens has confirmed that the Stratus(R) CS Acute Care(TM) D-Dimer CalPak calibrator lots 502058002 and 501318002 may exhibit SLOPE or CALCV error messages (instrument errors), which indicate calibration failures. | Terminated |
- INNOVANCE® D-Dimer 2.0 (SMN 10873803)K253985 · Siemens Healthcare Diagnostic Products GmbH · Aug 11, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 7, 2006
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7320
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files